February 22, 2017 12:56 PM ET


Company Overview of Immune Design Corp.

Key Executives for Immune Design Corp.

NameBoard RelationshipsTitleAge
Carlos V. Paya M.D., Ph.D.14 RelationshipsChief Executive Officer, President and Director57
Stephen R. Brady J.D., LLMNo RelationshipsPrincipal Financial Officer, Principal Accounting Officer and Executive Vice President of Strategy & Finance46
Adam R. Craig M.D., Ph.D., M.B.A.No RelationshipsInterim Chief Medical Officer50
Frank J. Hsu M.D.No RelationshipsHead of Oncology and Vice President--
Christopher Whitmore CPANo RelationshipsVice President of Finance & Administration--
View More Key Executives

Immune Design Corp. Board Members*

NameBoard RelationshipsPrimary CompanyAge
Edward Etienne Penhoet Ph.D. 92 RelationshipsAlta Partners LP75
Carlos V. Paya M.D., Ph.D. 14 RelationshipsImmune Design Corp.57
Rafi Ahmed Ph.D. 30 RelationshipsMetaclipse Therapeutics Corporation--
David Baltimore Ph.D. 65 RelationshipsPACT Pharma, Inc.78
William R. Ringo Jr. 107 RelationshipsPearl Street Venture Funds71
View All Board Members

Immune Design Corp. Executive Committees*

Committee NameChairpersonBoard RelationshipsMembers
Audit Committee CFA, BA, MA, MBAFranklin M. Berger111 Relationships3 Executives
Compensation Committee Jr.William R. Ringo107 Relationships3 Executives
Nominating Committee Ph.D.David Baltimore65 Relationships3 Executives
Corporate Governance Committee Ph.D.David Baltimore65 Relationships3 Executives
Advisory Board Ph.D.Rafi Ahmed30 Relationships8 Executives
View Committee Details
*Data is at least as current as the most recent Definitive Proxy.

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. Bloomberg.com does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup


  Industry Range
Not meaningful
Total Short Term Compensation$530.5K
Total Value of Options
Compensation as of Fiscal Year
Immune Design Corp. CEO Compensation
Industry Average


BioAegis Therapeutics Inc. Names John Kellum to its Clinical Advisory Board
February 21, 2017 6:01 PM ET
Marina Biotech Appoints Seymour Fein as Chief Medical Officer
February 21, 2017 2:05 PM ET
Anders Hove Joins ARCA Biopharma Board of Directors
February 21, 2017 1:30 PM ET
Acorda Therapeutics, Inc. Appoints Catherine D. Strader to its Board of Directors
February 21, 2017 12:00 PM ET
Edge Therapeutics, Inc. Appoints Alyssa Wyant as Senior Vice President, Regulatory Affairs
February 21, 2017 12:00 PM ET

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Immune Design Corp., please visit . Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.